Pfizer/Washington U. Tie-Up Involves Reprofiling Of Existing Compounds
This article was originally published in The Pink Sheet Daily
Executive Summary
Under five-year collaboration, university researchers will have access to more than 500 Pfizer compounds and their clinical and preclinical data.